Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JostRenggli
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JostRenggli
-
We just released the latest edition of our monthly Biotech financing summary pulled from data of Biotechgate. The total private equity financing amount and the number of rounds for US-based and European companies were lower in December than usual. http://www.biotechgate.com/web/cms/index.php/biotech_financing_report.html?utm_source=linkedInJre …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are loooking forward to BioTrinity 2020 - as participant as well as provider of the partnering system HelloPartnering - Speed Dating for Businesshttps://lnkd.in/e32i2-u
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have a position available for an internship as a life sciences and business analyst.
#Internship at Venture Valuation AG and Biotechgatehttps://lnkd.in/ek9CgsBHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pleased to be the official partnering provider of the GFFA conference https://lnkd.in/epER66m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have a position available for an internship as a life sciences and business analyst.
@VValuation@Biotechgate https://www.venturevaluation.com/documents/InternshipVentureValuation(Jan2020).pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
This month we are presenting the trend report for the Canadian life science market that shows the strong position of the country in the biotech industry. The total financing amount of the three largest rounds of 2019 alone exceeded a quarter billion USD. https://resourcecenter.biotechgate.com/2019/12/canadian-life-science-market-trend-analysis-2019 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The December edition of our monthly Biotech Financing Summary is available now. The total private equity financing amount for US-based and European companies was at its annual lowest in November, similarly to the total number of financing rounds. http://www.biotechgate.com/web/cms/index.php/biotech_financing_report.html …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Jost Renggli proslijedio/la je Tweet
Planning your 2020 Conference Diary? Make sure BioTrinity, 28-29 April, London is booked in, where we aim to inspire growth and create opportunities for all attendees, via a packed agenda that centres around partnering, investment and collaboration. https://biotrinity.com/register-here pic.twitter.com/ATQ9TA3ryJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting report provided by
@ifj_ch about Swiss start-up funding in November https://www.startup.ch/index.cfm?page=136925 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jost Renggli proslijedio/la je Tweet
Would you like to know what it takes to
#RaiseCapital? Read the article written by the@Biotechgate team about the real costs of#biotech#fundraising http://resourcecenter.biotechgate.com/2019/09/what-it-takes-to-raise-capital/ …pic.twitter.com/jrI8CMeghC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting technology: My colleague Mariko Hirano (Head of Japan Operations at
@VValuation ) interviewed Cyrill Bätscher, CEO of Advanced Osteotomy Tools about their laser osteotomy technology for bone surgery https://resourcecenter.venturevaluation.com/2019/11/interviews-with-leading-life-sciences-companies-aot …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In October, the total private equity financing amount for US-based and European companies exceeded USD 1,200 Million. It constitutes an increase of about 77% compared to September. Moreover, the number of financing rounds in the US…https://lnkd.in/eEfZwSM https://lnkd.in/dVnfPaX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There are two places left in our valuation course that will be delivered in London on the 4th of December. The participants will learn how to value a biotech company or therapeutic and how to structure a licensing deal.
@VValuation@CELforpharmahttps://www.celforpharma.com/course/signup?course=108 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jost Renggli proslijedio/la je Tweet
We are pleased to announce that our
#partnering system will be used at the "12th Global Forum for Food and Agriculture"#GFFA from 16-18 January 2020 in Berlin, organised by the German Federal Ministry of Food and Agriculture@bmel - https://gffa-berlin.de/en/ pic.twitter.com/Z7uFGgjcVz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jost Renggli proslijedio/la je Tweet
Lots of meetings today for our team but always time for a photo
#BIOEuropepic.twitter.com/K4rZCfUrGV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jost Renggli proslijedio/la je Tweet
Only 10 days to go!
@DxPx_Conference#dxpx2019 is taking place on 18 November and we are proud to provide our#partnering system for this event aimed at startups, companies &#investors in#AI#DigitalDiagnostics,#DigitalHealth and#research tools: https://dxpx-conference.com pic.twitter.com/ywsyDMeHhg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.